Breaking News

Scinai Immunotherapeutics Awarded Grant to Support New CDMO Biz

An approximately $900,000 project aims to ramp up CDMO services for drug development and GMP manufacturing for clinical trials.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Scinai Immunotherapeutics Ltd. was awarded a grant from the Israel Innovation Authority (IIA) covering 66% of the costs of an approximately $900,000 project aimed at ramping up Scinai’s new CDMO business unit. The grant is neither subject to repayment nor tied to royalty payments.   Scinai’s research and development capabilities specialize in developing innovative inflammation and immunology biologics to combat autoimmune and infectious diseases. Scinai’s CDMO services provide tailored drug de...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters